Mail

"Invention is alive and well in the US, but innovation - the successful commercialization of invention - is in steep decline." The Trouble with Tech Transfer Ed Silverman's "The Trouble with Tech Transfer" does not put the subject in context and focuses only on anecdotal evidence. Academic tech transfer offices were set up by institutions in response to the Bayh-Dole Act, which The Economist called "possibly the most inspired piece of legislation to be enacted in

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Ed Silverman's "The Trouble with Tech Transfer" does not put the subject in context and focuses only on anecdotal evidence. Academic tech transfer offices were set up by institutions in response to the Bayh-Dole Act, which The Economist called "possibly the most inspired piece of legislation to be enacted in America over the past half-century."

The results continue to this day: The forthcoming Association of University Technology Managers annual survey will record, for fiscal year 2005, 28,349 current, active commercialization licenses. Each represents a university-company relationship to develop a product to benefit people. There have been 3,641 such new products in the marketplace since 1998 and 5,171 new spinout companies based on academic research created since 1980, each creating economic activity in its region.

In the United States, this is an enormous endeavor, involving more than 190 research universities in all 50 states. Add the tech transfer opportunities pouring out ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies